Medical School
Anadolu University, 1991

Post-Graduate Training
Dokuz Eylül University, Medical Oncology, 2001

Professional Experience
Artvin (Compulsory Service), 1991-1993
Dokuz Eylül University Faculty of Medicine, Department of Internal Medicine, 1993-1998
Specialist Doctor at Dokuz Eylül University Faculty of Medicine, Adult Hematology-Oncology Department, 1998-2001
Assistant Professor at Adnan Menderes University Faculty of Medicine, Department of Internal Medicine, Medical Oncology Division, 2001-2006
Associate Professor at Adnan Menderes University Faculty of Medicine, Department of Internal Medicine, Medical Oncology Division, 2006-2011
Professor at Adnan Menderes University Faculty of Medicine, Department of Internal Medicine, Medical Oncology Division, 2011-2021
Professor of Medical Oncology at Medicana International Istanbul Hospital since 2021

Medical Interest
Adult Oncology Diseases
Chemotherapy Treatment
Immunotherapy Treatment

Special Experience
Adult Oncology Diseases
Chemotherapy Treatment
Immunotherapy Treatment

Scientific Publications
A1. Articles:,
1.Oktay E, Oflazoglu U, Varol Y, Tanriverdi O, Mermur N, Arda HU, Demir L, Keskin O, Ahmadli T, Somali I, Oztop I, Meydan N. The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma. J Cancer Res Ther. 2020 Jul- Sep;16(4):737-744. doi: 10.4103/jcrt.JCRT_1404_16. PMID: 32930112.
2.Peled N, Gillis R, Kilickap S, Froesch P, Orlov S, Filippova E, Demirci U, Christopoulos P, Cicin I, Basal FB, Yilmaz C, Fedor M, Korkmaz T, Paydas S, Gautschi O, Zirtiloglu A, Eralp Y, Cinkir HY, Sezer A, Erman M, Tural D, Turna H, Mazieres J, Dudnik E, Reguart N, Camidge DR, Ng TL, Şenler FÇ, Beypınar İ, Yazılıtaş D, Demirkazık A, Karaoğlu A, Okutur K, Coşkun HŞ, Şendur MAN, Isikdogan A, Cabuk D, Yumuk PF, Yıldız I, Kaplan MA, Özyılkan Ö, Öztop İ, Olmez OF, Aydin K, Aydıner A, Meydan N, Grinberg RD, Roisman LC. GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patients. Lung Cancer. 2020 Oct;148:48-54. doi:10.1016/ j.lungcan. 2020.07.022. Epub 2020 Jul 27. PMID: 32799090.
3.Benekli M, Gumus M, Ozkan M, Dane F, Elkiran ET, Cicin I, Sevinc A, Aliustaoglu M, Isikdogan A, Meydan N, Oksuzoglu B, Ozyilkan O, Artac M, Ozdemir F, Kilickap S. Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study. J Oncol Pharm Pract. 2020 Oct 13:1078155220963535. doi: 10.1177/1078155220963535. Epub ahead of print. PMID: 33050804.
4.Yersal Ö, Kaplan MA, Işikdoğan A, Özdemir N, Aliustaoğlu M, Barutca S, Erdoğdu Hİ, Meydan N. Molecular subtypes are prognostic for N3 breast cancer patients in the modern therapeutic era. Mol Clin Oncol. 2019 Jan;10(1):180-184. doi: 10.3892/mco.2018.1771. Epub 2018 Nov 19. PMID: 30655995; PMCID: PMC6313943.
5.Oktay E, Oflazoglu U, Varol Y, Tanriverdi O, Mermur N, Arda HU, Demir L, Keskin O, Ahmadli T, Somali I, Oztop I, Meydan N. The prognostic role of thyroid transcription factor-1 in lung adenocarcinoma. J Cancer Res Ther. 2018 Dec;14(Supplement):S1201-S1208. doi: 10.4103/jcrt.JCRT_1404_16. PMID: 30539871.
6.Yersal Ö, Eryilmaz U, Akdam H, Meydan N, Barutca S. Arterial Stiffness in Breast Cancer Patients Treated with Anthracycline and Trastuzumab-Based Regimens. Cardiol Res Pract. 2018 May 2;2018:5352914. doi: 10.1155/2018/5352914. PMID: 29854434; PMCID: PMC5954934.
7.Omar M, Tanriverdi O, Cokmert S, Oktay E, Yersal O, Pilancı KN, Menekse S, Kocar M, Sen CA, Ordu C, Goksel G, Meydan N, Barutca S; Turkish Descriptive Oncological Researches Group. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer. Clin Respir J. 2018 Mar;12(3):922-929. doi: 10.1111/crj.12605. Epub 2017 Jan 6. PMID: 28026133.
8.Aykan NF, Yalçın S, Turhal NS, Özdoğan M, Demir G, Özkan M, Yaren A, Camcı C, Akbulut H, Artaç M, Meydan N, Uygun K, Işıkdoğan A, Ünsal D, Özyılkan Ö, Arıcan A, Seyrek E, Tekin SB, Manavoğlu O, Özet A, Elkıran T, Dişçi R. Epidemiology of colorectal cancer in Turkey: A cross-sectional disease registry study (A Turkish Oncology Group trial). Turk J Gastroenterol. 2015 Mar;26(2):145-53. doi: 10.5152/tjg.2015.5685. PMID: 25835113.
9.Tanriverdi O, Avci N, Oktay E, Kalemci S, Pilanci KN, Cokmert S, Menekse S, Kocar M, Sen CA, Akman T, Ordu C, Goksel G, Meydan N, Barutca S. Pretreatment Serum Albumin Level is an Independent Prognostic Factor in Patients with Stage IIIB Non-Small Cell Lung Cancer: A Study of the Turkish Descriptive Oncological Researches Group. Asian Pac J Cancer Prev. 2015;16(14):5971-6. doi: 10.7314/apjcp.2015.16.14.5971. PMID: 26320482.
10.Tanriverdi O, Meydan N, Barutca S. Reconsideration of clinical and histopathological prognostic factors in breast cancer patients: a single center experience. Asian Pac J Cancer Prev. 2014;15(2):807-12. doi: 10.7314/apjcp.2014.15.2.807. PMID: 24568500.
11.Tanriverdi O, Kaytan-Saglam E, Ulger S, Bayoglu IV, Turker I, Ozturk-Topcu T, Cokmert S, Turhal S, Oktay E, Karabulut B, Kilic D, Kucukzeybek Y, Oksuzoglu B, Meydan N, Kaya V, Akman T, Ibis K, Saynak M, Sen CA, Uysal-Sonmez O, Pilancı KN, Demir G, Saglam S, Kocar M, Menekse S, Goksel G, Yapar-Taskoylu B, Yaren A, Uyeturk U, Avci N, Denizli B, Ilis-Temiz E. The clinical and pathological features of 133 colorectal cancer patients with brain metastasis: a multicenter retrospective analysis of the Gastrointestinal Tumors Working Committee of the Turkish Oncology Group (TOG). Med Oncol. 2014 Sep;31(9):152. doi: 10.1007/s12032-014-0152-z. Epub 2014 Aug 10. PMID: 25108599.
12.Tanriverdi O, Cokmert S, Oktay E, Pilanci KN, Menekse S, Kocar M, Sen CA, Avci N, Akman T, Ordu C, Goksel G, Meydan N. Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy: a study of the Turkish Descriptive Oncological Researches Group. Med Oncol. 2014 Oct;31(10):217. doi: 10.1007/s12032-014-0217-z. Epub 2014 Sep 13. PMID: 25216865.
13.Varol U, Oktay E, Yildirim M, Surmeli ZG, Dirican A, Meydan N, Karaca B, Karabulut B, Uslu R. Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the first-line treatment of metastatic colorectal cancer. Mol Clin Oncol. 2014 Jan;2(1):166-170. doi: 10.3892/mco.2013.212. Epub 2013 Nov 12. PMID: 24649328; PMCID: PMC3915705.
14.Tanriverdi O, Meydan N, Barutca S. Long-term effect of trastuzumab on QT dispersion in adjuvant treatment for patients with Her2 receptor positive breast cancer: a pilot study. Med Oncol. 2012 Dec;29(5):3265-71. doi: 10.1007/s12032-012-0291-z. Epub 2012 Jun 30. PMID: 22752572.
15. Somali I, Meydan N, Tarhan MO, Oztop I, Alacacioglu A, Yilmaz U. Efficacy and toxicity of lower dose UFT without leucovorin in metastatic gastric cancer patients. J BUON, Jul-Sep;14(3):429-33. (2009) PubMed PMID: 19810134.
16. Somali I, Alacacioglu A, Tarhan MO, Meydan N, Erten C, Usalp S, Yilmaz U. Cisplatin plus gemcitabine chemotherapy in taxane/anthracycline-resistant metastatic breast cancer. Chemotherapy, 55(3):155-60. (2009) PubMed PMID: 19390188.
17. Meteoglu I, Meydan N, Erkus M. Id-1: regulator of EGFR and VEGF and potential target for colorectal cancer therapy. J Exp Clin Cancer Res, Nov 12;27:69. (2008) PubMed PMID: 19014499.
18. Meteoglu I, Erdogdu IH, Meydan N, Erkus M, Barutca S. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues. J Exp Clin Cancer Res. Oct, 19;27: 53. (2008) PubMed PMID: 18928570; PubMed PMCID: PMC2577088.
19. Erkus M, Meteoglu I, Culhaci N, Meydan N, Erdogdu I. Does thymidine phosphorylase correlate with angiogenesis in intraductal carcinoma of the breast? Saudi Med J, Sep; 27 (9): 1329-33. (2006) PubMed PMID: 16951768.
20. Meydan N., Kundak I., Yavuzsen T., Oztop I., Barutca S., Yilmaz U., Alakavuklar MN, “Cardiotoxicity of deGramont’s regimen: Incidence, clinical characteristics and long-term follow-up,” Japanese Journal of Clinical Oncology, 35, 265–270 (2005)
21. Ceyhan C., Meydan N., Barutca S., Tekten T., Onbasili AO, Ozturk B., Unal S., “Ultrasound tissue characterization by integrated backscatter for analyzing fluorouracil induced myocardial damage,” Echocardiography-A Journal of Cardiovascular Ultrasound and Allied Techniques, 22, 233-238 (2005)
22. Dikicioglu E., Barutca S., Meydan N., Meteoglu I., “Biological characteristics of breast cancer at the primary tumour and the involved lymph nodes,” International Journal of Clinical Practice, 59, 1039-1044 (2005)
23. Barutca S., Meydan N., Akar H., Yavasoglu I., Kadikoylu G., Bolaman Z., “Efficacy and tolerability of amifostine in elderly cancer patients,” Current Therapeutic Research-Clinical and Experimental, 65, 113-124 (2004)
24. Ceyhan C., Meydan N., Barutca S., Tekten T., Onbasili AO., Ozturk B., Unal S., Bayrak I., “Influence of high dose leucovorin and 5-fluorouracil chemotherapy regimen on P wave duration and dispersion,” Journal of Clinical Pharmacy and Therapeutics, 29, 267-271 (2004)
25. Barutca S., Ceyhan C., Meydan N., Ozturk B., Tekten T., Onbasili A., Kadikoylu G., Bolaman Z., “A new perspective on cardiotoxicity of 5-fluorouracil: A novel research tool; cardiac ultrasonic integrated backscatter analysis indicates transient, subclinical myocardial dysfunction due to high-dose leucovorin and infusional 5-fluorouracil (HDLV5FU) regimen,” Chemotherapy,50, 113-118 (2004)
26. Meydan N., Barutca S., Caliskan S., Camsari T., “Urinary stone disease in diabetes mellitus,” Scandinavian Journal of Urology and Nephrology, 37, 64-70 (2003)

Case report, technical note, short article
1. Tanriverdi O, Meydan N, Barutca S, Ozsan N, Gurel D, Veral A. Anti-Yo antibody-mediated paraneoplastic cerebellar degeneration in a female patient with pleural malignant mesothelioma. Jpn J Clin Oncol. 2013 May;43(5):563-8. doi: 10.1093/jjco/hyt031. Epub 2013 Mar 8. PMID: 23475537.
2. Oktay E, Yersal O, Meydan N, Sağıroğlu M, Uyanık O, Barutca S. Nearly Complete Response of Brain Metastases from HER2 Overexpressing Breast Cancer with Lapatinib and Capecitabine after Whole Brain Irradiation. Case Rep Oncol Med. 2013;2013:234391. doi: 10.1155/2013/234391. Epub 2013 Sep 26. PMID: 24191208; PMCID: PMC3804136.
3. Tanriverdi O, Meydan N, Barutca S, Kadikoylu G, Sargin G, Tataroglu C, Culhaci N. Cutaneous metastasis of gallbladder adenocarcinoma in a patient with chronic lymphocytic leukemia: a case report and review of the literature. Ann Dermatol. 2013 Feb;25(1):99-103. doi: 10.5021/ad.2013.25.1.99. Epub 2013 Feb 14. PMID: 23467457; PMCID: PMC3582938.
4. Tanriverdi O, Barutca S, Meydan N. Relapse with isolated peritoneal metastasis in lung adenocarcinoma: case report and review of the literature. Contemp Oncol (Pozn). 2012;16(6):586-9. doi: 10.5114/wo.2012.32495. Epub 2013 Jan 4. PMID: 23788949; PMCID: PMC3687476.
5. Tanriverdi O, Unubol M, Taskin F, Meydan N, Sargin G, Guney E, Barutca S. Imatinib-associated bilateral gynecomastia and unilateral testicular hydrocele in male patient with metastatic gastrointestinal stromal tumor: a literature review. J Oncol Pharm Pract. 2012 Jun;18(2):303-10. doi: 10.1177/1078155211424629. Epub 2011 Oct 18. PMID: 22009701.
6. Tanriverdi Ö., Meydan N., Barutca S., Sargn G., Small intestine-derived gastrointestinal stromal tumour diagnosed synchronously with colon adenocarcinoma: a case report and review of the literature, Współcz Onkol, 15 (3): 175–179, (2011).
7. Kadikoylu G, Barutca S, Tataroglu C, Kafkas S, Erpek H, Meydan N, Yavasoglu I, Bolaman Z. Thrombotic thrombocytopenic purpura as the first manifestation of metastatic adenocarcinoma in a young woman. Transfus Apher Sci, Feb;42(1):39-42. Epub 2009 Nov 17. (2010)
8. Kadikoylu G, Yavasoglu I, Barutca S, Meydan N, Bolaman Z. Chronic myeloid leukemia following the treatment of rectal adenocarcinoma. Med Oncol. 2008;25(4):467-70. (2008)
9. Meydan N., Barutca S., Guney E., Boylu S., Savk O., Culhaci N., Ayhan M., “Brown Tumors Mimicking Bone Metastases,” J Natl Med Assoc, 98, 950-953 (2006)
10. Erdogan S., Barutca S., Yurekli Y., Meydan N., Koseoglu K., “Reversible metastatic visceral calcification detected by 99mTc-methylene diphosphonate bone scanning in breast cancer,” Journal of Bone and Mineral Metabolism, 23, 407-409 (2005)
11. Kundak I., Oztop I., Soyturk M., Ozcan MA., Yilmaz U., Meydan N., Gorken IB., Kupelioglu A., Alakavuklar M., “Paclitaxel-carboplatin induced radiation recall colitis,” Tumori, 90(2), 256-8 (2004)
12. Barutca S., Turgut M., Meydan N., Ozsunar Y., “Subthalamic nucleus tumor causing hyperphagia,” Neurologia Medico-Chirurgica (Tokyo), 43, 457-460 (2003)
13. Barutca S., Kadikoylu G., Meydan N., Bolaman Z., Gokcen A., Bal F., “Two autoimmune diseases: Hashimoto’s thyroiditis and vitiligo accompanying breast cancer; A coincidence?,” Journal of BUON., 8, 177-179 (2003).
14. Barutca S., Kadikoylu G., Bolaman Z., Meydan N., Yavasoglu I., “Extravasation of paclitaxel into breast tissue from central catheter port,” Supportive Care in Cancer, 10, 563-565 (2002)
Book review, article review, letter to the editor, abstract, discussion, etc.
1. Sen S., Barutca S., Meydan N., “Azygos lobe small cell carcinoma,” European Journal of Cardio-Thoracic Surgery, 26, 1041 (2004)
2. Barutca S., Meydan N., Barlak A., “Prevention of interleukin-2-induced severe bronchospasm with salbutamol,” Journal of Aerosol Medicine, 16, 183-184 (2003)
Published in journals scanned by indexes other than A1.2 SCI Science Citation Index-Expanded:
Case report, technical note, short article
1. Tanriverdi O, Unubol M, Taskin F, Meydan N, Sargin G, Guney E, Barutca S. Imatinib-associated bilateral gynecomastia and unilateral testicular hydrocele in male patient with metastatic gastrointestinal stromal tumor: a literature review. J Oncol Pharm Pract, Oct 18 (2011).
2. Ayvaz O, Yavasoglu I, Kadikoylu G, Meydan N, Barutca S, Bolaman Z. The development of gastric cancer in a patient with polycythemia Vera, 3P deletion, and JAK2 V617F mutation. J Gastrointest Cancer, Dec; 41(4):254-6 (2010).
3. Kiylioglu N., Meydan N., Barutca S., Akyol A., “Sub-acute sensory neuronopathy as a preceeding sign of recurrence in colon carcinoma,” International Journal of Gastrointestinal Cancer, 34, 135-137 (2003).
A1.4 Articles published in national peer-reviewed journals:

Full text original article
1. Çulhacı N., Meteoğlu İ., Ünal E., Özkara E., Özgün H., Meydan N., Erkuş M., Expression of cell cycle regulating proteins and apoptosis-related markers in colorectal adenomas and adenocarcinomas. Journal of ADU Faculty of Medicine, 11(3):9–14 (2010).
2. Breast cancer practice pattern study group. Treatment approches for metastatic breast cancer in Turkey. Turkish Journal of Cancer, 35 (2), 61-69, (2005)
3.Öztop İ., Yavuzşen T., Yımaz U., Çavdar C., Yaren A., Tarhan O., Meydan N., Sökmen S., Çamsarı T., Alakavuklar M., “Long-term permanent central venous injection in cancer patients catheter complications”, Turkish Journal of Hematology-Oncology, 14(2), 90-95 (2004).
4.Öztop İ., Yılmaz U., Havıtçıoğlu H., Şen M., Demirkan B., Özkal S., Kundak I., Barutca S., Meydan N., Manisalı M., Alakavuklar M., “1990-2002 Our experience on patients with soft tissue sarcoma that we followed between the years of 2003”, Turkish Journal of Hematology-Oncology, 13, 61-71 (2003).
5. Barutca S., Karagözlü A., Üstün H., Kundak I., Meydan N., Öztop İ., Yılmaz U., Alakavuklar MN., “Depression in patients with early-stage breast cancer receiving adjuvant chemotherapy and adversely affecting their mood factors”, Turkish Journal of Hematology-Oncology, 10, 217-221 (2000).
6. Üstün H., Barutca S., Yılmaz U, Şanlı E., Meydan N., “Evaluation of emesis secondary to chemotherapy in breast cancer patients with diabetes mellitus”, Turkish Diabetes Yearbook, 336-338 (1998-1999).
7. Üstün H., Yılmaz U., Barutca S., Şanlı E., Meydan N., Alakavuklar M., “Cancer and diabetes mellitus”, Turkish Diabetes Yearbook, 333-335 (1998-1999).
Compilation
1. Meydan N., Hormonal Therapy in Gynecological Cancers. Turkiye Klinikleri Medical Oncology, Special issue, 4(1):128-34 (2011).
2. Barutca S., Meydan N., Auto-immune phenomenon in lymphoma patients, Turkiye Klinikleri Medical Oncology, Special issue, 2(2), 25-30, (2009).
Case presentation, technical note, short article, book or article analysis, letter to the editor, abstract, discussion, etc.
1. Yüksel H, Küçük M, Sezer SD, Barutça S, Meydan N, Döger FK, Meteoğlu İ, Tanrıverdi Ö, Erkuş M. Primary vaginal squamous cell cancer secondary to ovarian cancer. Turkish Journal of Gynecological Oncology 2011; 14: 110-112.
2. Tanrıverdi Ö., Sargın G., Döger FK., Meydan N., Barutca S., Inflammatory Pseudotumor in the Spleen: A Case Report. Haseki Medical Bulletin, 49: 84-7 (2011).
3. Tanrıverdi Ö., Meydan N., Barutca S., Recurrent supraventricular tachycardia associated with lapatinib: a case report of a probable cardiac adverse effect. Journal of Breast Health, Vol: 7 Issue: 3 (2011).
4. Yavaşoğlu İ., Kadıköylü G., Barutca S., Meydan N., Bolaman Z., Development of acute myeloblastic leukemia in a case diagnosed with breast cancer 24 and 4 years ago. Turkish Journal of Oncology, 25(2):73-76 (2010).
5. Tanrıverdi Ö., Cengiz O., Tataroglu., Meydan N., Barutca S., Retroperitoneal Liposarcoma: A Case Report. Haseki Medical Bulletin, 48: 166-8 (2010).
6. Meydan N., Barutça S., Özgün H., Taşkın F., Yüksel H., Boylu Ş., “Recurrent medullary breast cancer after twin pregnancy”, Journal of Breast Health, 2(1), 31-33 (2006) ).
7. Uslu G., Karaman G., Uslu M, Şavk E., Şendur N., Meydan N., “Hand-foot syndrome developed in a patient receiving capecitabine treatment”, Türkderm, 40: 105-7 (2006)
8. Meydan N., Ayhan M., Barutca S., Güney E., Boylu S., “A case of Brown tumor with normocalcemia mimicking metastatic bone disease”, Journal of ADU Faculty of Medicine, 6, 33-36 (2005) ). (Note: It is a different case from the case published in J Natl Med Assoc.)
9. Köseoğlu K., Çildağ B., Taşkın F., Meydan N., Barutça S., Treatment of cystic liver metastasis that causes lower extremity edema with inferior vena cava compression with percutaneous drainage. Journal of ADU Faculty of Medicine, 6(1), 35-37 (2005).
10. Breast Cancer Practice Pattern Study Group. Treatment approches for metastatic breast cancer in Turkey. Turkish Journal of Cancer, 35(2), 61-69 (2005).
11. Köseoğlu K., Yaycıoğlu S., Meydan N., Kıyılıoğlu N., “Multicentric glioma imaging with Magnetic Resonance”, Kocatepe Medical Journal, 5, 55-57 (2004).
12. Ceyhan C., Meydan N., Tekten T., Onbaşılı A.O., Barutca S., Öztürk B., “Acute transient diastolic dysfunction induced by 5-fluorouracil treatment: A case report”, Archives of the Turkish Society of Cardiology (Archives of the Turkish Society of Cardiology), 32, 262-265 (2004).
13. Kıylıoğlu N., Meydan N., Barutca S., Akyol A., Bölükbaşı O., “Lambert-Eaton myasthenic syndrome: Case report”, Turkish Journal of Neurological Sciences (on-line journal) 19, #17 (2002 ).
14. Barutca S., Meydan N., Yılmaz U., Alakavuklar MN., Özer E., “Bifocal mucinous cystadenocarcinoma of pancreatic and peritoneal localization. (A case report)”, Turkish Journal of Ecopathology, 6, 191-194 (2000).

A1.4 Articles published in other national journals:
Compilation
1. Barutca S., Meydan N., New developments in cancer treatment – new trends, Journal of Clinical Actuel Medicine, Oncology Special Issue, 11(10):31-37, (2006).
A3. Books:
A3.1 Published by international publishers or organizations:
1. Barutca S., Meydan N., “Chapter IX. Gemcitabine in advanced ovarian cancer”, Treatment of Ovarian Cancer. A.P. Bardos (Editor). Vol. 13, 181-210, Nova Science Publishers, New-York, U.S.A, 2005.
A3.2 Published by national publishers or organizations:
1. Decent SQUARE. “Biological Basis of Targeted Therapies in Breast Cancer” Molecular Approach to Breast Cancer, ISBN: 978-975-483-928-9, Ege University Press, 2011.

2. “Practical Information on Internal Diseases”, Editor: Mehmet Tunca, 141-145, Egem Publishing, 1998.
Meydan N., Kozan Ö., “Chapter 4. Heart Diseases: Approach to the patient with chest pain”, “Practical Information on Internal Medicine”, Editor: Mehmet Tunca, 141-145, Egem Publishing, 1998.
Meydan N., Kozan Ö., “Chapter 4. Heart Diseases: Symptoms in Cardiology”, “Practical Information on Internal Diseases”, Editor: Mehmet Tunca, 146-153, Egem Publishing, 1998.
Meydan N., Kozan Ö., “Chapter 4. Heart Diseases: Coronary Artery Disease”, “Practical Information on Internal Diseases”, Editor: Mehmet Tunca, 154-159, Egem Publishing, 1998.
Meydan N., Kozan Ö., “Chapter 4. Heart Diseases: Treatment of Angina pectoris”, “Practical Information on Internal Diseases”, Editor: Mehmet Tunca, 160-166, Egem Publishing, 1998.
Meydan N., Kozan Ö., “Chapter 4. Heart Diseases: Myocardial Infarction”, “Practical Information on Internal Diseases”, Editor: Mehmet Tunca, 167-182, Egem Publishing, 1998.
Meydan N., Kozan Ö., “Chapter 4. Heart Diseases: Heart Failure”, “Practical Information on Internal Diseases”, Editor: Mehmet Tunca, 197-213, Egem Publishing, 1998.
Meydan N., Çamsarı T., “Chapter 6. Nephrology: Approach to the patient with hematuria”, “Practical Information on Internal Diseases”, Editor: Mehmet Tunca, 275-283, Egem Publishing, 1998.
Meydan N., Çamsarı T., “Chapter 6. Nephrology: Acute kidney failure”, “Practical Information on Internal Diseases”, Editor: Mehmet Tunca, 284-295, Egem Publishing, 1998.
Quick N., Meydan N., “Chapter 6. Rheumatology: Systemic lupus erythematosus”, “Practical Information on Internal Diseases”, Editor: Mehmet Tunca, 391-398, Egem Publishing, 1998.

A4. Translating:
A4.2 Foreign language translation:
Department Editor
1. Meydan N. “Neoplastic Disorders, Chapter 6” “Harrison's Principles of Internal Medicine 17th edition” Fauci, Braunwald, Kasper, Hauser, Longo, Jameson, Loscalzo. McGraw-Hill Professional 2008. İzmir Güven Medicine Bookstore, In Print.
chapter in the book
1. Meydan N. “Cancer Cell Biology and Angiogenesis, Chapter 6, Part 80” “Harrison's Principles of Internal Medicine 17th edition” Fauci, Braunwald, Kasper, Hauser, Longo, Jameson, Loscalzo. McGraw-Hill Professional 2008. İzmir Güven Medicine Bookstore, In Print.
2. Meydan N. “Breast Cancer, Chapter 6, Part 86” “Harrison's Principles of Internal Medicine 17th edition” Fauci, Braunwald, Kasper, Hauser, Longo, Jameson, Loscalzo. McGraw-Hill Professional 2008. İzmir Güven Medicine Bookstore, In Print.
3. Meydan N. “Bladder and Renal Cell Carcinomas, Chapter 6, Part 90” “Harrison’s Principles of Internal Medicine 17th edition” Fauci, Braunwald, Kasper, Hauser, Longo, Jameson, Loscalzo. McGraw-Hill Professional 2008. İzmir Güven Tıp Kitabevi, Baskıda.
4. Meydan N. “Benign and Malignant Disease Of The Prostate, Chapter 6, Part 91” “Harrison’s Principles of Internal Medicine 17th edition” Fauci, Braunwald, Kasper, Hauser, Longo, Jameson, Loscalzo. McGraw-Hill Professional 2008. İzmir Güven Tıp Kitabevi, Baskıda.
5. Meydan N. “Paraneoplastik Neurologic Syndores, Chapter 6, Part 91” “Harrison’s Principles of Internal Medicine 17th edition” Fauci, Braunwald, Kasper, Hauser, Longo, Jameson, Loscalzo. McGraw-Hill Professional 2008. İzmir Güven Tıp Kitabevi, Baskıda.
B. Research projects:
B1. International research projects:
Taking part in the Project
1. FIGHT: A Phase 3 Randomized, Double-Blind, Controlled Study Evaluating FPA144 and Modified FOLFOX6 in Patients with Previously Untreated Advanced Gastric and Gastroesophageal Cancer: Phase 3 Preceded by Dose-Finding in Phase 1 (2019-2020)
2. Lume Lung 2 : BIBF 1120 Plus Pemetrexed Compared to Placebo Plus Pemetrexed in 2nd Line Nonsquamous NSCLC. (2009)
3. CPT-V 306: Open label, randomized multicenter phase II/III study of irinotecan (CPT-11) in combination with cisplatine (CDDP) or CPT-11 in combination with 5-FU compared to a combination of CDDP and 5-FU in patients with metastatic or locally recurrent gastric cancer previously untreated with chemotherapy or advanced disease. (2005)
4. CPT-V 306: Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer. (2005)
B2. National research projects:
Taking part in the project supported by national organizations
1. Evaluation of Tyrosine kinase Inhibitors (TKIs) Treatment Sriresin in Patients with Metastatic Renal Cell Carcinoma (mRCC) Who Cannot Tolerate Cytokine Therapy: National, Multicenter, Observational Study (TURCOS). (2015)
2. National Observational Study Evaluating the Efficacy and Safety of Filgrastim in Patients with Chemotherapy-Induced Neutropenia. (2011)
3. Profile of the colorectal cancer patients in Turkey: A cross-sectional disease registry study; A Turkish Oncology Group trial. KOLON TURK study (2009)
4. The Effect of Breast Tumor Removal as Primary Treatment on Survival in Patients Diagnosed with Metastatic Breast Cancer at First Admission, (Study MF07-01).
Supporting institution: Federation of Breast Diseases Associations. (2008)